Studio di fase I/II multicentrico e in aperto volto a valutare la sicurezza, l'efficacia, la farmacocinetica e la farmacodinamica di DCC-3014 in pazienti affetti da tumori in stadio avanzato e tumore tenosinoviale a cellule giganti.

Title

Code

DCC-3014-01-001

Type

Sperimentale con farmaco

Start Year

2021

Status

In Corso

Principal Investigator

051-6366199

anna.paioli@ior.it

Paioli Anna, MD

Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies

Operational unit that carry out the study

complex unit

Osteoncologia, Sarcomi dell'osso e dei tessuti molli, e Terapie Innovative

Director

Ibrahim Toni, BSc, MSc, MD, PhD

Go to the details >>

Description

Studio clinico promosso da Deciphera Pharmaceuticals, LLC, United States.

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. DCC-3014-01-001

Thursday 28 August 2025, 15:50

PG0005735_2021_Nulla osta DG_DCC-3014-01-001 - Palmerini.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Studio di fase I/II multicentrico e in aperto volto a valutare la sicurezza, l'efficacia, la farmacocinetica e la farmacodinamica di DCC-3014 in pazienti affetti da tumori in stadio avanzato e tumore tenosinoviale a cellule giganti.

Principal Investigator

Operational unit that carry out the study

Description

Documents and Videos attachament

You might also be interested in